For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230502:nRSB1282Ya&default-theme=true
RNS Number : 1282Y Agronomics Limited 02 May 2023
2 May 2023
Agronomics Limited
("Agronomics" or the "Company")
Net Asset Value calculation as at 31 March 2023
Agronomics Limited (AIM:ANIC), the leading listed company focused on the field
of cellular agriculture, announces that its unaudited Net Asset Valuation
("NAV") calculation as at closing on 31 March 2023 was 16.14 pence per share,
broadly unchanged from 16.37 pence per share at 31 December 2022. Net Assets
stand at £160 million, including investments of £131 million and uninvested
cash of £29 million.
The share price of 10.90 pence at the 31 March 2023 close represents a
discount of 32% to the NAV per share. The average discount to NAV per share
over the last 12-month period was 4%. Under IFRS, the Company's unquoted
investments are generally carried at cost or the most recent priced funding
round.
Richard Reed, Chairman of Agronomics, commented: -
"Agronomics welcomed a new company to the portfolio this quarter, through its
participation in the successful US$ 3.3 million Pre-seed financing of Wild
Microbes, a company developing next-generation microbes for biomanufacturing.
This quarter also saw the second approval of a cultivated chicken product by
the US Food and Drug Administration ("FDA"), with Good Meat receiving a 'No
Questions letter'. The FDA is one of the most stringent regulatory bodies
globally for food safety, and we still await the US Department of Agriculture
to approve a cultivated meat product, allowing companies to begin
commercialisation. We expect to see more regulatory approvals in the US for
cultivated meat in the near term."
Corporate
On 23 February 2023, the Company announced the appointment of Marisa Drew to
the Board of Directors. Marisa Drew is the inaugural Chief Sustainability
Officer ("CSO") of Standard Chartered Bank Plc, responsible for setting the
bank's sustainability strategy and the delivery of the firm's commitment to
net zero carbon emissions by 2050 as well as overseeing the sustainable
finance client-facing activities of the bank.
Financing
During the quarter ended 31 March 2023, the Company received notification of
warrants being exercised. A total of 1,142 new ordinary shares were issued
following the warrant exercise, for proceeds of £342.60. These funds,
together with existing cash resources, will be utilised to provide finance for
opportunities within the field of cellular agriculture, both by supporting
existing companies, as well as identifying new opportunities in which to
invest.
Investment review
On 25 January 2023, Liberation Labs Inc announced the acquisition of the land
for its launch facility, which we believe will be the first dedicated,
purpose-built, commercial, precision fermentation plant globally for food
production.
On 7 February 2023, cultivated meat company CellX Limited announced the
signing of a strategic partnership agreement with food manufacturing
specialists Shanghai Tofflon Science and Technology Co., Ltd., aiming to
accelerate the scale-up of cultivated meat in the Asian market with a new
purpose-built facility.
On 23 February 2023, Agronomics participated in Wild Microbes US $3.3 million
pre-Seed funding round, with a US$ 0.5 million investment. The investment was
completed in the form of a Simple Agreement for Future Equity, and will
provide Agronomics on conversion with an approximate equity ownership of 4.17%
on a fully diluted basis. Wild Microbes' proprietary technology will allow it
to genetically engineer novel microbial strains for use as host-organisms to
produce proteins and other high value molecules.
Unaudited to
31 March 2023
£
Current Assets
Investments 130,895,484
Uninvested cash and deposits 29,254,287
Trade and other receivables 93,021
Current Liabilities
Trade and other creditors (52,161)
Net Assets 160,190,631
Capital and Reserves
Share capital 992
Share premium 134,209,188
Retained earnings 25,980,451
Net assets 160,190,631
Shares in Issue 992,244,668
Net Asset Value per share 16.14 pence
The quoted investments within the portfolio are valued under IFRS at bid
price.
This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic
Law by virtue of the European Union (Withdrawal) Act 2018. Upon the
publication of this announcement, this inside information is now considered to
be in the public domain.
For further information please contact:
Agronomics Beaumont Canaccord Genuity Limited Cenkos Peterhouse Capital TB Cardew
Limited Cornish Limited Securities Plc Limited
The Company Nomad Joint Broker Joint Broker Joint Broker Public Relations
Richard Reed Roland Cornish Andrew Potts Giles Balleny Lucy Williams Ed Orlebar
Denham Eke James Biddle Harry Rees Michael Johnson Charles Goodfellow Alistair Walker
Alex Aylen (Head of Equities)
+44 (0) 1624 639396 +44 (0) 207 628 3396 +44 (0) 207 523 8000 +44 (0) 207 397 8900 +44 (0) 207 469 0936 +44 (0) 20 7930 0777
info@agronomics.im +44 (0) 7738 724 630
agronomics@tbcardew.com
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCBLLFBXELXBBQ